NCT04607226View on ClinicalTrials.gov

Effects of Respiratory-Gated Transcutaneous Vagal Nerve Stimulation in Major Depression (Phase 1)

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

October 12, 2022

Study Completion Date

October 12, 2022

Conditions
Major Depressive Disorder
Interventions
OTHER

Active transcutaneous vagus nerve stimulation

respiratory-gated non-painful electrical stimulation of the auricle for 30 minutes

OTHER

Sham transcutaneous vagus nerve stimulation

stimulation of the auricle for 30 minutes

Trial Locations (1)

02129

Massachusetts General Hospital, Charlestown

Sponsors
All Listed Sponsors
collaborator

Brain & Behavior Research Foundation

OTHER

lead

Massachusetts General Hospital

OTHER